+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 50Years +
MALE
ID07648888

Comparison of Water Vapor Thermal Therapy and Ejaculation-Sparing Bipolar Transurethral Enucleation in Men with Symptomatic Benign Prostatic Hyperplasia

Led by Beni-Suef University · Updated on 2026-06-15

120

Participants Needed

1

Research Sites

4 weeks

Total Duration

AI-Summary

What This Trial Is About

This research aims to compare two treatments for sexually active men aged 50 and older who have symptomatic benign prostatic hyperplasia BPH with moderate-to-severe lower urinary tract symptoms. The study evaluates Water Vapor Thermal Therapy WVTTRezum against Ejaculation-Sparing Bipolar Transurethral Enucleation of the Prostate ES-B-TUEP. The goal is to assess urinary symptom relief and the preservation of ejaculation, which is important for postoperative satisfaction in this population. Participants will receive one of two procedures based on shared decision-making with their surgeon after counseling. The first treatment, Water Vapor Thermal Therapy, involves delivering radiofrequency-generated water vapor into the enlarged prostate tissue via a cystoscope, including treatment of the median lobe when suitable, followed by Foley catheter placement. The second treatment, Ejaculation-Sparing Bipolar Transurethral Enucleation, is a surgical technique that removes prostate tissue while preserving structures important for ejaculation, also ending with catheter placement. This is a prospective, controlled, non-randomized study. Participants will undergo baseline assessments including medical, urological, and sexual history, physical and digital rectal exams, various laboratory tests, and ultrasound imaging. Follow-up visits occur at 1, 3, 6, and 12 months after treatment to monitor urinary symptoms, sexual function, urine flow, residual urine volume, complications, medication use, and any retreatment. The main measurement is the change in Male Sexual Health Questionnaire-Ejaculatory Dysfunction Short Form Function domain score from baseline to 12 months. Safety and treatment outcomes will be closely tracked throughout the study.

CONDITIONS

Brief Title

Water Vapor Thermal Therapy Versus Ejaculation-Sparing Bipolar Transurethral Enucleation for Benign Prostatic Hyperplasia

Research Team

H

Hany F Badawy, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here